Login to Your Account



Other News To Note


Wednesday, August 15, 2012

• Genkyotex SA, of Geneva, reported positive results from studies of GKT137831, for liver fibrosis, showing the ability to attenuate development of fibrosis in the liver and attenuate production of reaction oxygen species in two models of the disease.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription